Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma
Authors
Keywords
-
Journal
OncoImmunology
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2019-03-28
DOI
10.1080/2162402x.2019.1593811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE
- (2018) Debra H Josephs et al. ALLERGY
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study
- (2018) R. Arthur et al. INTERNATIONAL JOURNAL OF CANCER
- miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
- (2018) Anne-Marie Givel et al. Nature Communications
- Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells
- (2018) Sonja Lieber et al. OncoImmunology
- Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts
- (2018) Gautier Stoll et al. OncoImmunology
- Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
- (2017) T L Mao et al. GENE THERAPY
- Cohort Profile: The AMORIS cohort
- (2017) Göran Walldius et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- C-reactive protein and risk of ovarian cancer
- (2017) Jing Li et al. MEDICINE
- Machine Learning-Assisted Network Inference Approach to Identify a New Class of Genes that Coordinate the Functionality of Cancer Networks
- (2017) Mehrab Ghanat Bari et al. Scientific Reports
- Cancer therapy in a microbial bottle: Uncorking the novel biology of the protozoan Toxoplasma gondii
- (2017) Barbara A. Fox et al. PLoS Pathogens
- The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling
- (2017) G Nappo et al. Oncogenesis
- Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies
- (2017) Géraldine Genard et al. Frontiers in Immunology
- Epidemiology of ovarian cancer: a review
- (2017) Reid Brett M. et al. Cancer Biology & Medicine
- CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
- (2016) Holger Bronger et al. BRITISH JOURNAL OF CANCER
- Effects of the balance between type 1 and type 2 T helper cells on ovarian cancer
- (2016) C.J. Hao et al. GENETICS AND MOLECULAR RESEARCH
- Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells
- (2016) Dan Wang et al. Oncotarget
- Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models
- (2016) Hye Lim Lee et al. Oncotarget
- Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients
- (2015) Wahyu Wulaningsih et al. CARCINOGENESIS
- Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer
- (2015) Nonna Kolomeyevskaya et al. GYNECOLOGIC ONCOLOGY
- Tapping CD4 T Cells for Cancer Immunotherapy: The Choice of Personalized Genomics
- (2015) Maurizio Zanetti JOURNAL OF IMMUNOLOGY
- Understanding Local Macrophage Phenotypes In Disease: Modulating macrophage function to treat cancer
- (2015) Vincenzo Bronte et al. NATURE MEDICINE
- Machine learning applications in genetics and genomics
- (2015) Maxwell W. Libbrecht et al. NATURE REVIEWS GENETICS
- Current clinical application of serum biomarkers to detect ovarian cancer
- (2015) Marek Nowak et al. Przeglad Menopauzalny
- Haptoglobin and CCR2 receptor expression in ovarian cancer cells that were exposed to ascitic fluid: Exploring a new role of haptoglobin in the tumoral microenvironment
- (2015) OL Garibay-Cerdenares et al. Cell Adhesion & Migration
- CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
- (2015) Zuqiang Liu et al. OncoImmunology
- Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course
- (2015) An Coosemans et al. OncoImmunology
- Machine learning applications in cancer prognosis and prediction
- (2015) Konstantina Kourou et al. Computational and Structural Biotechnology Journal
- Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients
- (2015) Melina Helbling et al. Oncotarget
- IL4 Receptor ILR4 Regulates Metastatic Colonization by Mammary Tumors through Multiple Signaling Pathways
- (2014) K. T. Venmar et al. CANCER RESEARCH
- A Signature Predicting Poor Prognosis in Gastric and Ovarian Cancer Represents a Coordinated Macrophage and Stromal Response
- (2014) R. A. Busuttil et al. CLINICAL CANCER RESEARCH
- Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma
- (2014) RAJESH SINGH et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Ovarian Cancer Biology and Immunotherapy
- (2014) T. Sree Latha et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
- (2014) Paola Italiani et al. Frontiers in Immunology
- AttenuatedListeria monocytogenesreprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis
- (2014) Patrick H Lizotte et al. OncoImmunology
- Avirulent Toxoplasma gondii Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer Microenvironment
- (2013) Jason R. Baird et al. CANCER RESEARCH
- Epidemiological associations of allergy, IgE and cancer
- (2013) Debra H. Josephs et al. CLINICAL AND EXPERIMENTAL ALLERGY
- The Immune System in the Pathogenesis of Ovarian Cancer
- (2013) Bridget Charbonneau et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11
- (2013) Hong Namkoong et al. VACCINE
- The Tumor Microenvironment: A Pitch for Multiple Players
- (2013) Giovanna Schiavoni et al. Frontiers in Oncology
- Immuno-oncology: understanding the function and dysfunction of the immune system in cancer
- (2012) O. J. Finn ANNALS OF ONCOLOGY
- Improved Outcome of High-Risk Early HER2 Positive Breast Cancer With High CXCL13-CXCR5 Messenger RNA Expression
- (2012) Evangelia Razis et al. Clinical Breast Cancer
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- Immune Response Evaluation Through Determination of Type 1, Type 2, and Type 17 Patterns in Patients With Epithelial Ovarian Cancer
- (2012) Eduardo Batista Cândido et al. Reproductive Sciences
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
- (2011) H. Kulbe et al. CANCER RESEARCH
- Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer
- (2011) Kristine H. Allin et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
- (2011) Lucia De Monte et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IgE Mediates Killing of Intracellular Toxoplasma gondii by Human Macrophages through CD23-Dependent, Interleukin-10 Sensitive Pathway
- (2011) Ioannis Vouldoukis et al. PLoS One
- A Case-Control Study of Asthma and Ovarian Cancer
- (2010) Wafic M. ElMasri et al. Archives of Environmental & Occupational Health
- Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
- (2010) Ingar Holme et al. ATHEROSCLEROSIS
- Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch
- (2010) W. Ding et al. BLOOD
- High IL-12 p35 and IL-23 p19 mRNA expression is associated with superior outcome in ovarian cancer
- (2010) Anna Maria Wolf et al. GYNECOLOGIC ONCOLOGY
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection
- (2009) Cláudia N. Paiva et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Multianalyte Profiling of Serum Antigens and Autoimmune and Infectious Disease Molecules to Identify Biomarkers Dysregulated in Epithelial Ovarian Cancer
- (2008) G. P. Bertenshaw et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Macrophages and cancer
- (2008) Alessandra Nardin Frontiers in Bioscience-Landmark
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- A snapshot of microarray-generated gene expression signatures associated with ovarian carcinoma
- (2008) B. GYÖRFFY et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now